UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist

The Journal of pharmacology and experimental therapeutics, 1994-07, Vol.270 (1), p.228

1994

Volltextzugriff (PDF)

Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage

The FASEB journal, 2001-08, Vol.15 (10), p.1822

2001

Volltextzugriff (PDF)

Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site

Bioorganic & medicinal chemistry letters, 1999-05, Vol.9 (10), p.1397-1402

1999

Volltextzugriff (PDF)

Potent Vasoconstriction Mediated by Endothelin ETB Receptors in Canine Coronary Arteries

Circulation research, 1994-01, Vol.74 (1), p.105-114

1994

Volltextzugriff (PDF)

Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-κB Activation in Angiotensin II–Induced Cardiac Injury

Hypertension (Dallas, Tex. 1979), 2001-02, Vol.37 (2, Part 2 Suppl), p.787-793

2001

Volltextzugriff (PDF)

Downregulation of endothelin receptors by autocrine production of endothelin-1

American Journal of Physiology: Cell Physiology, 1993-07, Vol.265 (1), p.C188-C192

1993

Volltextzugriff (PDF)

Endothelin antagonism with bosentan : a review of potential applications

Journal of molecular medicine (Berlin, Germany), 1999-04, Vol.77 (4), p.364-376

1999

Volltextzugriff (PDF)

Monocyte Infiltration and Adhesion Molecules in a Rat Model of High Human Renin Hypertension

Hypertension (Dallas, Tex. 1979), 1999-01, Vol.33 (1S Suppl), p.389-395

1999

Volltextzugriff (PDF)

Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium

Circulation (New York, N.Y.), 1999-04, Vol.99 (14), p.1802-1809

1999

Volltextzugriff (PDF)

Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use

The Journal of pharmacology and experimental therapeutics, 1999-08, Vol.290 (2), p.840

1999

Volltextzugriff (PDF)

The pharmacology of bosentan

Expert opinion on investigational drugs, 1998-07, Vol.7 (7), p.1173-1192

1998

Volltextzugriff (PDF)

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

Nature (London), 1993-10, Vol.365 (6448), p.759-761

1993

Volltextzugriff (PDF)

Effect of Bosentan on NF-κB, Inflammation, and Tissue Factor in Angiotensin II–Induced End-Organ Damage

Hypertension (Dallas, Tex. 1979), 2000-08, Vol.36 (2), p.282-290

2000

Volltextzugriff (PDF)

Hypertension-induced end-organ damage : A new transgenic approach to an old problem

Hypertension (Dallas, Tex. 1979), 1999, Vol.33 (1), p.212-218

1999

Volltextzugriff (PDF)

Absence of ET(B)-mediated contraction in Piebald-lethal mice

Life sciences (1973), 1997, Vol.61 (3), p.255-263

1997

Volltextzugriff (PDF)

Blood Pressure–Independent Effects in Rats With Human Renin and Angiotensinogen Genes

Hypertension (Dallas, Tex. 1979), 2000-02, Vol.35 (2), p.587-587

2000

Volltextzugriff (PDF)

Piperidine renin inhibitors: from leads to drug candidates

Farmaco (Società chimica italiana : 1989), 2001-01, Vol.56 (1), p.21-27

2001

Volltextzugriff (PDF)

Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm

The Journal of pharmacology and experimental therapeutics, 1997-12, Vol.283 (3), p.1110

1997

Volltextzugriff (PDF)

The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo

Biochemical and biophysical research communications, 1992-07, Vol.186 (2), p.867-873

1992

Volltextzugriff (PDF)

Angiotensin II (AT 1) Receptor Blockade Reduces Vascular Tissue Factor in Angiotensin II-Induced Cardiac Vasculopathy

The American journal of pathology, 2000-07, Vol.157 (1), p.111-122

2000

Volltextzugriff (PDF)

In Vivo Pharmacology of Ro 46-2005, The First Synthetic Nonpeptide Endothelin Receptor Antagonist: Implications for Endothelin Physiology

Journal of cardiovascular pharmacology, 1993, Vol.22 Suppl 8 (Supplement 8), p.S377-S379

1993

Volltextzugriff (PDF)

Cyclosporin A Protects Against Angiotensin II–Induced End-Organ Damage in Double Transgenic Rats Harboring Human Renin and Angiotensinogen Genes

Hypertension (Dallas, Tex. 1979), 2000-01, Vol.35 (1, Part 2 Suppl), p.360-360

2000

Volltextzugriff (PDF)

Formation of 5-aminolevulinate via glutamate-1-semialdehyde and 4,5-dioxovalerate with participation of an RNA component in Scenedesmus obliquus mutant C-2A

Biochimica et biophysica acta, 1988-11, Vol.967 (2), p.135-140

1988

Volltextzugriff (PDF)

Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma

FEBS letters, 1993-10, Vol.333 (1), p.108-110

1993

Volltextzugriff (PDF)

Up-Regulation of Endothelin-B Receptors in Atherosclerotic Human Coronary Arteries

Journal of cardiovascular pharmacology, 1996-01, Vol.27 (1), p.147-153

1996

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Englisch
(106)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(70)
Life Sciences & Biomedicine
(54)
Biological And Medical Sciences
(44)
Animals
(41)
Humans
(35)
Medical Sciences
(28)
Rats
(27)
Male
(23)
Endothelin
(20)
Endothelin Receptor Antagonists
(19)
Pharmacology. Drug Treatments
(18)
Pharmacology & Pharmacy
(17)
Cardiovascular System & Cardiology
(16)
Fundamental And Applied Biological Sciences. Psychology
(16)
Physical Sciences
(14)
Blood Pressure - Drug Effects
(12)
Cardiovascular System
(12)
Sulfonamides - Pharmacology
(12)
Chemistry
(11)
Animals, Genetically Modified
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist

Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage

Substituted piperidines - highly potent renin inhibitors due to induced fit adaptation of the active site

Potent Vasoconstriction Mediated by Endothelin ETB Receptors in Canine Coronary Arteries

Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-κB Activation in Angiotensin II–Induced Cardiac Injury

Downregulation of endothelin receptors by autocrine production of endothelin-1

Endothelin antagonism with bosentan : a review of potential applications

Monocyte Infiltration and Adhesion Molecules in a Rat Model of High Human Renin Hypertension

Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium

Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use

The pharmacology of bosentan

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist

Effect of Bosentan on NF-κB, Inflammation, and Tissue Factor in Angiotensin II–Induced End-Organ Damage

Hypertension-induced end-organ damage : A new transgenic approach to an old problem

Absence of ET(B)-mediated contraction in Piebald-lethal mice

Blood Pressure–Independent Effects in Rats With Human Renin and Angiotensinogen Genes

Piperidine renin inhibitors: from leads to drug candidates

Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm

The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo

Angiotensin II (AT 1) Receptor Blockade Reduces Vascular Tissue Factor in Angiotensin II-Induced Cardiac Vasculopathy

In Vivo Pharmacology of Ro 46-2005, The First Synthetic Nonpeptide Endothelin Receptor Antagonist: Implications for Endothelin Physiology

Cyclosporin A Protects Against Angiotensin II–Induced End-Organ Damage in Double Transgenic Rats Harboring Human Renin and Angiotensinogen Genes

Formation of 5-aminolevulinate via glutamate-1-semialdehyde and 4,5-dioxovalerate with participation of an RNA component in Scenedesmus obliquus mutant C-2A

Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma

Up-Regulation of Endothelin-B Receptors in Atherosclerotic Human Coronary Arteries

Suchergebnisse filtern